Issued Patents 2020
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10722509 | Predicting optimal chemotherapy for CRC | Fabiola CECCHI | 2020-07-28 |
| 10725051 | Multiplex MRM assay for evaluation of cancer | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2020-07-28 |
| 10725045 | Quantifying MGMT protein for optimal cancer therapy of glioblastoma | Fabiola CECCHI, Dongyao YAN | 2020-07-28 |
| 10722531 | OPRT expression and cancer treatment outcome | Fabiola CECCHI, Dongyao YAN | 2020-07-28 |
| 10718780 | SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein | David B. Krizman, Adele Blackler, Wei-Li Liao | 2020-07-21 |
| 10620223 | SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein | David B. Krizman, Sheeno Thyparambil, Wei-Li Liao | 2020-04-14 |
| 10620184 | SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein | David B. Krizman, Eunkyung An | 2020-04-14 |
| 10617717 | Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy | Fabiola CECCHI, Jean-Charles Soria | 2020-04-14 |
| 10585099 | SRM/MRM assays for cancer | Fabiola CECCHI, Sarit SCHWARTZ, Kerry SCOTT | 2020-03-10 |
| 10537576 | Methods for treating Her2-positive breast cancer | Adele Blackler, Fabiola CECCHI, Paolo Nuciforo | 2020-01-21 |